UK Parliament home

Closed Fund access to abiraterone in England for high-risk prostate cancer patients

Closed on

Abiraterone has been available in Scotland and Wales for two years for high-risk patients whose cancer has not yet spread but not in England and Northern Ireland. I want the government fund abiraterone for men in England, giving them the treatment they deserve and has been proven to work.

I think it is unfair that men are not receiving the treatment.
Research has shown that for these earlier stage patients, the survival rate after six years is improved and that the drug halved the rate of progression of the cancer.

1,032 signatures

Show on a map

10,000

Petition progress

View all updates for this petition, with the most recent first.

  • Petition closed

  • Related activity

    Access to abiraterone for the treatment of prostate cancer: debate in Parliament

    On 17 June, MPs debated access to abiraterone for the treatment of prostate cancer.

    This was an adjournment debate led by Dr Rupa Huq MP. Health Minister, Karin Smyth MP, responded on behalf of the Government.

    Explainer

    Adjournment debates give an MP the opportunity to debate a topic they choose, and receive a response from the Government.

    They are a way to:

    • raise awareness of an issue
    • seek to influence government policy
    • put the views of the MP and the Government on record.

    They do not involve a vote on a particular action or decision.

    The debates take place at the end of each day in the House of Commons. They last for 30 minutes.

    Our visual explainer explains how they work.

    Your UK Parliament newsletter

    Sign up to a regular newsletter on the work of Parliament and how to get involved.

  • Petition published

    This petition can now be signed.

    If this petition gets 10,000 signatures, government will respond to it.

    If this petition gets 100,000 signatures, it will be considered for debate in Parliament.

    This petition will stay open until 17 October 2025.